Difference between revisions of "Team:MIT"

Line 43: Line 43:
 
     <a href="https://2016.igem.org/Team:MIT/future">
 
     <a href="https://2016.igem.org/Team:MIT/future">
 
       <img src="https://static.igem.org/mediawiki/2016/6/64/T--MIT--FutureButton.svg" alt="Future work, designs, and collaborations" >
 
       <img src="https://static.igem.org/mediawiki/2016/6/64/T--MIT--FutureButton.svg" alt="Future work, designs, and collaborations" >
       <span class="text-content"><span><br>We worked with experts in endometriosis to lay out a basic clinical plan,<br> designed a possible full circuit using our synthetic biological parts,<br> and collaborated with the BU Hardware team to test and confirm that mammalian cells can grow in a microfluidics device.<br><br><br><br><br>Read more about the future applications of our work</span></span>
+
       <span class="text-content"><span><br><br><br><br><br><br><br><br><br><br><br><br><br><br>Read more about future applications of our work through circuit design, clinical aspects, and iGEM collaborations<br><br></span></span>
 
     </a>
 
     </a>
 
   </li>
 
   </li>

Revision as of 20:10, 16 October 2016


This diagnostic process can be expedited by using the following synthetic biological tools to sense molecular markers in endometrial biopsy samples.


We've successfully created new, hormone-inducible mammalian promoters,
characterized a miRNA sensing platform in TERT-immortalized human endometrial stromal cells (tHESC) culture under varying estrogen conditions,
and tested the functionality of a serine integrase (TP901) in a mammalian line as a biological latch.

We've spent a long time visualizing how these tools could be used in the long term to help patients with endometriosis.



Genetic circuit to sense endometriosis

Some of our team's achievements this year include:

  1. Developed novel estrogen and progesterone inducible synthetic mammalian promoters through bottom-up promoter engineering. These constructs could resolve the changes in estrogen and progesterone signaling characteristic of endometriosis

  2. Characterized the functionality of a miRNA sensing platform in TERT immortalized human endometrial stromal cells (tHESC). We are one of the first to characterize changes in miRNA activity in the cell line with and without estrogen.

  3. Characterized the functionality of a serine integrase (TP901) in a mammalian cell line. Recombinases like TP901 downstream of a tunable L7Ae - kturn system that we implemented could help process input from our estrogen, progesterone, and miRNA sensors and adjust output as per a patient's needs.

  4. Transfected larger 4 to 5 transcriptional unit genetic circuits that cascaded our devices together in order to explore how our sensors interact with one another.



UPLOAD FILES